NEW YORK, Feb. 28 (GenomeWeb News) - In recent weeks, investment bank analysts have started to promote Solexa. Pacific Growth Equities has initiated coverage with a 'buy' rating, and Leerink Swann & Company has given the stock an 'outperform' rating.
...and receive Daily News bulletins.
Already have an account?Login Now.
Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.
The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.
In Science this week: genetic overlap among many psychiatric disorders, and more.
The Economist writes that an increasing number of scientific journals don't do peer review.